Physician profile
James A Harris
NPI 1235222431
$967.59
in general payments reported to CMS, 2019-2025
20 companies · $82.76 in 2025
The $82.76 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $35.08 · 2021: $192 · 2022: $144 · 2023: $143 · 2024: $182 · 2025: $82.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $282.30 | 2021-2024 | Signia |
| Imbed Biosciences INC. | $96.58 | 2023 | |
| Sun Pharmaceutical Industries INC. | $96.45 | 2019 | |
| Smith+Nephew, INC. | $83.93 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Abbott Laboratories | $60.26 | 2019-2022 | |
| Intra-Sana Laboratories | $47.10 | 2021-2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Ethicon US, LLC | $43.01 | 2019-2022 | |
| Integra Lifesciences Corporation | $35.68 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novo Nordisk INC | $33.06 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $31.54 | 2022 | |
| Hologic INC | $22.15 | 2022 | |
| Heron Therapeutics, INC. | $19.40 | 2023 | Aponvie |
| Daiichi Sankyo INC. | $16.33 | 2020 | |
| Davol INC. | $16.32 | 2021 | |
| Covidien LP | $15.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $14.90 | 2022 | |
| Hologic Sales and Service, LLC | $14.40 | 2023 | Localizer, Trunode, Biozorb |
| Kerecis Limited | $13.59 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.96 | 2023 | Exparel, Iovera |
| Lemaitre Vascular, INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.